StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Price Performance
Shares of XXII opened at $0.10 on Friday. 22nd Century Group has a fifty-two week low of $0.08 and a fifty-two week high of $5.28. The company has a market capitalization of $4.61 million, a price-to-earnings ratio of 0.00 and a beta of 1.45. The firm has a 50-day simple moving average of $0.14 and a 200-day simple moving average of $0.51. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.
Institutional Inflows and Outflows
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Recommended Stories
- Five stocks we like better than 22nd Century Group
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Learn Technical Analysis Skills to Master the Stock Market
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- 5 discounted opportunities for dividend growth investors
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.